Senior Manager, Scientific Affairs Life Sciences

Illinois, United States

Apply with AI Apply

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Life Sciences, Healthcare, Biotechnology, PharmaceuticalsIndustries

Requirements

Candidates should possess a fundamental understanding of molecular oncology and clinical patient management diagnostic algorithms, with extensive working knowledge of phase I-IV oncology drug development programs and processes. Exceptional interpersonal communication, writing, public speaking, and inter/intradepartmental management skills are required, along with strong business acumen and the ability to define strategies and manage operational plans. A self-starter with an ownership mindset is essential.

Responsibilities

The Senior Manager, Scientific Affairs will act as an internal scientific/technical expert on Tempus oncology test offerings, contributing to the development of scientifically accurate marketing messages and collateral for stakeholders. They will review and approve Life Science Marketing/Strategic Operations promotional content, provide medical support and education to the Life Sciences Business Development Team for incorporating Tempus NGS and multi-omics tests into pharmaceutical drug trials, and maintain market intelligence on competitor products. Responsibilities also include supporting pipeline profiling, providing clinical and scientific perspectives in client engagement meetings, networking with internal stakeholders to identify collaboration opportunities, closing education gaps for internal teams, responding to medical information requests, and attending oncology congresses to support potential pharmaceutical clients and the Medical Affairs team.

Skills

Oncology

Therapeutics

Diagnostics

NGS

Multi-omics

Companion Diagnostics

Pharmaceutical Development

Market Intelligence

Scientific Communication

Medical Affairs

Tempus

AI-driven healthcare data analysis platform

About Tempus

Tempus focuses on enhancing patient outcomes through the use of data and artificial intelligence in healthcare. The company offers a platform that analyzes medical data to provide insights for physicians, helping them make better treatment decisions. This platform also aids pharmaceutical and biotech companies in drug development by identifying new targets and assessing treatment effectiveness. For patients, Tempus identifies personalized therapy options, particularly in cancer care, where their research has shown increased opportunities for tailored treatments. They have developed a pan-cancer organoid platform and a liquid biopsy assay for profiling circulating tumor DNA. Tempus generates revenue by charging healthcare providers and companies for access to their platform and insights, setting them apart from competitors by their focus on personalized medicine and extensive cancer research.

Chicago, IllinoisHeadquarters

2015Year Founded

$894.9MTotal Funding

IPOCompany Stage

AI & Machine Learning, Biotechnology, HealthcareIndustries

1,001-5,000Employees

Benefits

Relocation Assistance

Company Equity

Performance Bonus

Risks

Competition from partners like Genialis may lead to conflicts of interest.

Ambry Genetics acquisition could pose financial risks if synergies aren't realized.

Technical challenges may arise in integration with Flatiron's OncoEMR platform.

Differentiation

Tempus uses AI to analyze clinical and molecular data for precision medicine.

Their platform aids in personalized treatment decisions for cancer patients.

Tempus collaborates with biotech firms to enhance drug development using real-world data.

Upsides

Increased AI adoption in healthcare boosts Tempus' partnerships and collaborations.

Acquisition of Ambry Genetics expands Tempus' genetic testing capabilities.

Integration with Flatiron's OncoEMR enhances precision in cancer treatment plans.

Land your dream remote job 3x faster with AI

Try Jobo Free